Nanxi Chen

807 total citations · 2 hit papers
10 papers, 634 citations indexed

About

Nanxi Chen is a scholar working on Molecular Biology, Molecular Medicine and Pharmaceutical Science. According to data from OpenAlex, Nanxi Chen has authored 10 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Molecular Medicine and 3 papers in Pharmaceutical Science. Recurrent topics in Nanxi Chen's work include Curcumin's Biomedical Applications (4 papers), Extracellular vesicles in disease (3 papers) and Advanced Drug Delivery Systems (3 papers). Nanxi Chen is often cited by papers focused on Curcumin's Biomedical Applications (4 papers), Extracellular vesicles in disease (3 papers) and Advanced Drug Delivery Systems (3 papers). Nanxi Chen collaborates with scholars based in China, United States and Portugal. Nanxi Chen's co-authors include Bo Xiao, Brandon S.B. Canup, Menghang Zu, Fangyin Dai, Dengchao Xie, Yuqi Liang, Yuming Fu, Chenhui Wang, Qiubing Chen and Liang Zeng and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Nanoscale.

In The Last Decade

Nanxi Chen

9 papers receiving 631 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation

2021 233 citations Qiubing Chen, Qian Li et al. Acta Pharmaceutica Sinica B profile →
‘Green’ nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases

2021 228 citations Menghang Zu, Dengchao Xie et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanxi Chen China	8	430	195	85	60	55	10	634
Pablo García‐Manrique Spain	11	290 0.7×	117 0.6×	110 1.3×	36 0.6×	56 1.0×	17	511
Brandon S.B. Canup United States	13	605 1.4×	261 1.3×	158 1.9×	121 2.0×	172 3.1×	20	1.0k
Heliang Song China	11	221 0.5×	63 0.3×	75 0.9×	38 0.6×	96 1.7×	15	477
Haiting Xu China	15	316 0.7×	65 0.3×	98 1.2×	72 1.2×	120 2.2×	33	791
Yibin Fan China	14	269 0.6×	66 0.3×	82 1.0×	89 1.5×	69 1.3×	53	960
Yuan Lyu China	16	325 0.8×	61 0.3×	42 0.5×	52 0.9×	38 0.7×	40	547
Krishna Yadav India	19	302 0.7×	61 0.3×	123 1.4×	149 2.5×	135 2.5×	47	748
Meysam Soleimani Iran	14	266 0.6×	86 0.4×	72 0.8×	97 1.6×	56 1.0×	41	551
Jonggwan Park South Korea	13	463 1.1×	92 0.5×	103 1.2×	98 1.6×	19 0.3×	26	832

Countries citing papers authored by Nanxi Chen

Since Specialization

Citations

This map shows the geographic impact of Nanxi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanxi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanxi Chen more than expected).

Fields of papers citing papers by Nanxi Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanxi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanxi Chen. The network helps show where Nanxi Chen may publish in the future.

Co-authorship network of co-authors of Nanxi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Nanxi Chen. A scholar is included among the top collaborators of Nanxi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanxi Chen. Nanxi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Chen, Nanxi, Ye He, Yuxuan Zhang, et al.. (2025). Mannose and phenylboronate ester functionalized mesoporous silica nanoparticles contained in chitosan microneedles for enhancing cellular immunity and antitumor efficacy. Theranostics. 16(4). 2080–2100.

2.

Zu, Menghang, Nanxi Chen, Li Chen, et al.. (2024). Oral exosome-like nanovesicles from Phellinus linteus suppress metastatic hepatocellular carcinoma by reactive oxygen species generation and microbiota rebalancing. Nanoscale. 16(16). 8046–8059. 8 indexed citations

3.

He, Ye, Nanxi Chen, Jinghai Zhang, et al.. (2024). Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization. Journal of Controlled Release. 368. 430–443. 19 indexed citations

4.

Gao, Qiang, Nanxi Chen, Menghang Zu, et al.. (2024). Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route. Journal of Nanobiotechnology. 22(1). 4–4. 42 indexed citations

5.

Chen, Nanxi, Jianfeng Sun, Zhenhua Zhu, Adam P. Cribbs, & Bo Xiao. (2022). Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions. Expert Opinion on Drug Delivery. 19(4). 409–419. 30 indexed citations

6.

Chen, Qiubing, Qian Li, Yuqi Liang, et al.. (2021). Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation. Acta Pharmaceutica Sinica B. 12(2). 907–923. 233 indexed citations breakdown →

7.

Zu, Menghang, Dengchao Xie, Brandon S.B. Canup, et al.. (2021). ‘Green’ nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases. Biomaterials. 279. 121178–121178. 228 indexed citations breakdown →

8.

Gou, Shuangquan, Nanxi Chen, Xiaoai Wu, et al.. (2021). Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy. Acta Pharmaceutica Sinica B. 12(1). 406–423. 21 indexed citations

9.

Yang, Wenjing, Dengchao Xie, Yuqi Liang, et al.. (2021). Multi-responsive fibroin-based nanoparticles enhance anti-inflammatory activity of kaempferol. Journal of Drug Delivery Science and Technology. 68. 103025–103025. 7 indexed citations

10.

Huang, Yamei, Brandon S.B. Canup, Shuangquan Gou, et al.. (2020). Oral nanotherapeutics with enhanced mucus penetration and ROS-responsive drug release capacities for delivery of curcumin to colitis tissues. Journal of Materials Chemistry B. 9(6). 1604–1615. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact